Los Angeles Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.8K | Buy |
37,655
+21,101
| +127% | +$36.3K | ﹤0.01% | 1285 |
|
|
2025
Q1 | $55.1K | Sell |
16,554
-45,205
| -73% | -$151K | ﹤0.01% | 1073 |
|
|
2024
Q4 | $457K | Hold |
61,759
| – | – | ﹤0.01% | 832 |
|
|
2024
Q3 | $580K | Buy |
61,759
+37,635
| +156% | +$353K | ﹤0.01% | 823 |
|
|
2024
Q2 | $193K | Buy |
+24,124
| New | +$193K | ﹤0.01% | 1132 |
|
|
2020
Q4 | – | Sell |
-7,335
| Closed | -$241K | – | 1528 |
|
|
2020
Q3 | $241K | Sell |
7,335
-20,766
| -74% | -$682K | ﹤0.01% | 1338 |
|
|
2020
Q2 | $771K | Buy |
28,101
+5,855
| +26% | +$161K | ﹤0.01% | 947 |
|
|
2020
Q1 | $666K | Sell |
22,246
-2,695
| -11% | -$80.7K | ﹤0.01% | 817 |
|
|
2019
Q4 | $690K | Hold |
24,941
| – | – | ﹤0.01% | 931 |
|
|
2019
Q3 | $454K | Sell |
24,941
-23,389
| -48% | -$426K | ﹤0.01% | 1014 |
|
|
2019
Q2 | $1.19M | Sell |
48,330
-13,730
| -22% | -$337K | 0.01% | 790 |
|
|
2019
Q1 | $590K | Buy |
+62,060
| New | +$590K | ﹤0.01% | 1036 |
|